Extra‑abdominal recurrent aggressive fibromatosis: A case series and a literature review.

IF 1.4 Q4 ONCOLOGY
Molecular and clinical oncology Pub Date : 2023-09-07 eCollection Date: 2023-10-01 DOI:10.3892/mco.2023.2680
Saywan K Asaad, Ari M Abdullah, Shkar Ali Abdalrahman, Fattah H Fattah, Soran H Tahir, Choman Sabah Omer, Rezheen J Rashid, Marwan N Hassan, Shvan H Mohammed, Fahmi H Kakamad, Berun A Abdalla
{"title":"Extra‑abdominal recurrent aggressive fibromatosis: A case series and a literature review.","authors":"Saywan K Asaad,&nbsp;Ari M Abdullah,&nbsp;Shkar Ali Abdalrahman,&nbsp;Fattah H Fattah,&nbsp;Soran H Tahir,&nbsp;Choman Sabah Omer,&nbsp;Rezheen J Rashid,&nbsp;Marwan N Hassan,&nbsp;Shvan H Mohammed,&nbsp;Fahmi H Kakamad,&nbsp;Berun A Abdalla","doi":"10.3892/mco.2023.2680","DOIUrl":null,"url":null,"abstract":"<p><p>Aggressive fibromatosis is a rare clonal proliferative tumor arising from mesenchymal cells in the fascia and musculoaponeurotic structures. The aim of the present study was to describe several cases of extra-abdominal recurrent aggressive fibromatosis. The present study was a single-center retrospective case series of patients with recurrent aggressive fibromatosis. The cases were managed at a single private facility. A total of 9 patients with recurrent fibromatosis were included. The mean and median ages of the patients were 29 and 30 years, respectively. In total, two thirds (66.67%) of the cases were female. A negative previous medical history was reported in 7 cases (77.7%), and diabetes and hypertension were reported in 1 case (11.1%). Overall, only 1 case (11.1%) had a family history of breast fibromatosis. The time interval between primary tumor resection and recurrent presentation was 28 months. In 6 cases (66.7%), the tumor was located in the extremities. Pain was the most common presenting symptom in 6 cases (66.7%). All patients had their recurring tumor surgically removed, followed by radiation in 5 cases. The resection margin was positive in 4 cases (44.4%). Each patient was subjected to a careful three-month follow-up for recurrences. On the whole, the present study demonstrates that despite the fact that several therapeutic approaches for extra-abdominal recurrent aggressive fibromatosis have been described in the literature, there is a significant likelihood of recurrence following resection.</p>","PeriodicalId":18737,"journal":{"name":"Molecular and clinical oncology","volume":"19 4","pages":"84"},"PeriodicalIF":1.4000,"publicationDate":"2023-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5c/a7/mco-19-04-02680.PMC10557105.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular and clinical oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3892/mco.2023.2680","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aggressive fibromatosis is a rare clonal proliferative tumor arising from mesenchymal cells in the fascia and musculoaponeurotic structures. The aim of the present study was to describe several cases of extra-abdominal recurrent aggressive fibromatosis. The present study was a single-center retrospective case series of patients with recurrent aggressive fibromatosis. The cases were managed at a single private facility. A total of 9 patients with recurrent fibromatosis were included. The mean and median ages of the patients were 29 and 30 years, respectively. In total, two thirds (66.67%) of the cases were female. A negative previous medical history was reported in 7 cases (77.7%), and diabetes and hypertension were reported in 1 case (11.1%). Overall, only 1 case (11.1%) had a family history of breast fibromatosis. The time interval between primary tumor resection and recurrent presentation was 28 months. In 6 cases (66.7%), the tumor was located in the extremities. Pain was the most common presenting symptom in 6 cases (66.7%). All patients had their recurring tumor surgically removed, followed by radiation in 5 cases. The resection margin was positive in 4 cases (44.4%). Each patient was subjected to a careful three-month follow-up for recurrences. On the whole, the present study demonstrates that despite the fact that several therapeutic approaches for extra-abdominal recurrent aggressive fibromatosis have been described in the literature, there is a significant likelihood of recurrence following resection.

Abstract Image

腹部外复发性侵袭性纤维瘤病:一个病例系列和一篇文献综述。
侵袭性纤维瘤病是一种罕见的克隆性增殖性肿瘤,由筋膜和肌肉筋膜结构中的间充质细胞引起。本研究的目的是描述几个腹部外复发性侵袭性纤维瘤病的病例。本研究为复发性侵袭性纤维瘤病患者的单中心回顾性病例系列。这些案件是在一个单独的私人设施中处理的。共纳入9例复发性纤维瘤病患者。患者的平均年龄和中位年龄分别为29岁和30岁。总的来说,三分之二(66.67%)的病例是女性。7例(77.7%)既往病史为阴性,1例(11.1%)报告糖尿病和高血压。总体而言,只有1例(11.1%)有乳腺纤维瘤病家族史。原发性肿瘤切除和复发之间的时间间隔为28个月。6例(66.7%)肿瘤位于四肢。疼痛是6例(66.7%)患者最常见的症状。所有患者都通过手术切除了复发的肿瘤,5例接受了放疗。4例(44.4%)患者的切除率为阳性。每个患者都对复发进行了为期三个月的仔细随访。总的来说,本研究表明,尽管文献中已经描述了几种治疗腹部外复发性侵袭性纤维瘤病的方法,但切除后复发的可能性很大。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.80
自引率
0.00%
发文量
108
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信